These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 37798679)
21. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy. Ono M; Komatsu M; Ji B; Takado Y; Shimojo M; Minamihisamatsu T; Warabi E; Yanagawa T; Matsumoto G; Aoki I; Kanaan NM; Suhara T; Sahara N; Higuchi M Aging Cell; 2022 Jul; 21(7):e13615. PubMed ID: 35662390 [TBL] [Abstract][Full Text] [Related]
22. Peripheral nervous system effects in the PS19 tau transgenic mouse model of tauopathy. Merchán-Rubira J; Sebastián-Serrano Á; Díaz-Hernández M; Avila J; Hernández F Neurosci Lett; 2019 Apr; 698():204-208. PubMed ID: 30677432 [TBL] [Abstract][Full Text] [Related]
23. Cryo-EM structures of τ filaments from human brain. Goedert M Essays Biochem; 2021 Dec; 65(7):949-959. PubMed ID: 34846514 [TBL] [Abstract][Full Text] [Related]
24. Conformation determines the seeding potencies of native and recombinant Tau aggregates. Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315 [TBL] [Abstract][Full Text] [Related]
25. Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brains. Yang Y; Zhang W; Murzin AG; Schweighauser M; Huang M; Lövestam S; Peak-Chew SY; Saito T; Saido TC; Macdonald J; Lavenir I; Ghetti B; Graff C; Kumar A; Nordberg A; Goedert M; Scheres SHW Acta Neuropathol; 2023 Mar; 145(3):325-333. PubMed ID: 36611124 [TBL] [Abstract][Full Text] [Related]
26. Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy. Choi YB; Dunn-Meynell AA; Marchese M; Blumberg BM; Gaindh D; Dowling PC; Lu W Alzheimers Res Ther; 2021 Jan; 13(1):32. PubMed ID: 33504364 [TBL] [Abstract][Full Text] [Related]
27. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Clavaguera F; Akatsu H; Fraser G; Crowther RA; Frank S; Hench J; Probst A; Winkler DT; Reichwald J; Staufenbiel M; Ghetti B; Goedert M; Tolnay M Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9535-40. PubMed ID: 23690619 [TBL] [Abstract][Full Text] [Related]
28. Mutations in MAPT give rise to aneuploidy in animal models of tauopathy. Rossi G; Conconi D; Panzeri E; Paoletta L; Piccoli E; Ferretti MG; Mangieri M; Ruggerone M; Dalprà L; Tagliavini F Neurogenetics; 2014 Mar; 15(1):31-40. PubMed ID: 24218087 [TBL] [Abstract][Full Text] [Related]
29. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease. Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751 [TBL] [Abstract][Full Text] [Related]
30. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. Iba M; Guo JL; McBride JD; Zhang B; Trojanowski JQ; Lee VM J Neurosci; 2013 Jan; 33(3):1024-37. PubMed ID: 23325240 [TBL] [Abstract][Full Text] [Related]
31. Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice. Kim J; Selvaraji S; Kang SW; Lee WT; Chen CL; Choi H; Koo EH; Jo DG; Leong Lim K; Lim YA; Arumugam TV Brain Behav Immun; 2019 Aug; 80():344-357. PubMed ID: 30980950 [TBL] [Abstract][Full Text] [Related]
32. Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice. Walker CK; Greathouse KM; Boros BD; Poovey EH; Clearman KR; Ramdas R; Muhammad HM; Herskowitz JH Neuroscience; 2021 Feb; 455():195-211. PubMed ID: 33346120 [TBL] [Abstract][Full Text] [Related]
33. Frontotemporal dementia with Parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation. Maeda S; Sato Y; Takashima A Neurobiol Aging; 2018 Sep; 69():26-32. PubMed ID: 29852407 [TBL] [Abstract][Full Text] [Related]
34. A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy. Eteläinen TS; Silva MC; Uhari-Väänänen JK; De Lorenzo F; Jäntti MH; Cui H; Chavero-Pieres M; Kilpeläinen T; Mechtler C; Svarcbahs R; Seppälä E; Savinainen JR; Puris E; Fricker G; Gynther M; Julku UH; Huttunen HJ; Haggarty SJ; Myöhänen TT Sci Transl Med; 2023 Apr; 15(691):eabq2915. PubMed ID: 37043557 [TBL] [Abstract][Full Text] [Related]
35. Structures of filaments from Pick's disease reveal a novel tau protein fold. Falcon B; Zhang W; Murzin AG; Murshudov G; Garringer HJ; Vidal R; Crowther RA; Ghetti B; Scheres SHW; Goedert M Nature; 2018 Sep; 561(7721):137-140. PubMed ID: 30158706 [TBL] [Abstract][Full Text] [Related]
36. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury. Parra Bravo C; Krukowski K; Barker S; Wang C; Li Y; Fan L; Vázquez-Rosa E; Shin MK; Wong MY; McCullough LD; Kitagawa RS; Choi HA; Cacace A; Sinha SC; Pieper AA; Rosi S; Chen X; Gan L Mol Neurodegener; 2024 Jun; 19(1):51. PubMed ID: 38915105 [TBL] [Abstract][Full Text] [Related]
37. Brain cellular senescence in mouse models of Alzheimer's disease. Dorigatti AO; Riordan R; Yu Z; Ross G; Wang R; Reynolds-Lallement N; Magnusson K; Galvan V; Perez VI Geroscience; 2022 Apr; 44(2):1157-1168. PubMed ID: 35249206 [TBL] [Abstract][Full Text] [Related]
38. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies. Rockenstein E; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Bisquert A; Trejo-Morales M; Spencer B; Masliah E PLoS One; 2015; 10(3):e0121570. PubMed ID: 25803611 [TBL] [Abstract][Full Text] [Related]
39. Tau silencing by siRNA in the P301S mouse model of tauopathy. Xu H; Rösler TW; Carlsson T; de Andrade A; Fiala O; Hollerhage M; Oertel WH; Goedert M; Aigner A; Höglinger GU Curr Gene Ther; 2014; 14(5):343-51. PubMed ID: 25687501 [TBL] [Abstract][Full Text] [Related]